NovaBay Pharmaceuticals, Inc. Interest Expense (Operating)

Interest Expense (Operating) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Interest Expense (Operating) growth rates and interactive chart.


Highlights and Quick Summary

  • Interest Expense (Operating) for the quarter ending September 30, 2020 was $16 Thousand (a -81.4% decrease compared to previous quarter)
  • Year-over-year quarterly Interest Expense (Operating) decreased by -96.35%
  • Annual Interest Expense (Operating) for 2020 was $275 Thousand (a -73.88% decrease from previous year)
  • Twelve month Interest Expense (Operating) ending September 30, 2020 was $728 Thousand
Trailing Interest Expense (Operating) for the last four month:
30 Sep '20
$728 Thousand
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Interest Expense (Operating) of NovaBay Pharmaceuticals, Inc.

Most recent Interest Expense (Operating)of NBY including historical data for past 10 years.

Interactive Chart of Interest Expense (Operating) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Interest Expense (Operating) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $0.02 $0.09 $0.19 $0.28
2019 $0.44 $1.05

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology